# Vibegron (Gemtesa)

Source: https://ourhealthnetwork.com/drugs/vibegron
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Vibegron?

Vibegron (brand name: Gemtesa) is a beta3-adrenergic agonist. It is prescribed to treat urinary bladder, overactive. Across the United States, 13,000 doctors prescribe Vibegron to approximately 134,000 Medicare patients.

## Brand names

Gemtesa

## Indications

Vibegron is prescribed for the treatment of urinary bladder and overactive.

## Conditions treated

- [Urinary Bladder](https://ourhealthnetwork.com/conditions/urinary-bladder)
- [Overactive](https://ourhealthnetwork.com/conditions/overactive)

## Mechanism of action

Vibegron is a selective human beta-3 adrenergic receptor agonist. Activation of the beta-3 adrenergic receptor increases bladder capacity by relaxing the detrusor smooth muscle during bladder filling.

## Drug classification

- Established Pharmacologic Class: beta3-Adrenergic Agonist [EPC]
- Mechanism of Action class: Adrenergic beta3-Agonists [MoA]
- Route of administration: ORAL

## Common side effects

and bronchitis, and female, diarrhea, nasopharyngitis, nausea, upper respiratory tract infection, urinary tract infection, were urinary tract infection

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)